A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...
Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...
The following first ran on CounterPunch at the height of the COVID pandemic in January of 2022. Are anti-vaccine ...
Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...
We recently published a list of These 10 Stocks Were Wednesday’s Worst Performers. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands among Wednesday’s ...
It can happen even after a mild case and at any age, although rates have declined since the pandemic’s early years. Studies show vaccination can lower the risk. It also is not clear what causes long ...
6don MSN
RNA vaccine developer Moderna (MRNA) is sinking 9% after Goldman Sachs downgraded the shares to Neutral from Buy. Why Goldman Cut Its Rating on MRNA Earlier this month, Moderna reduced its 2025 ...
The mRNA-1273.815 vaccine provided significant protection against COVID-19-related hospitalizations and medically attended COVID-19 among US adults.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback